We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B Turnover 17.35%
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18
Avg Time Held Equity + Options
2.2 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
4 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DB icon
151
Deutsche Bank
DB
$61.2B
$539K 0.04%
33,814
+3,285
+11% +$53.7K
2023 Q3
3 quarters
SLYG icon
152
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.7B
$520K 0.04%
+6,057
New +$518K
2024 Q2
0 quarters
ALC icon
153
Alcon
ALC
$32B
$518K 0.04%
5,814
+1,649
+40% +$141K
2024 Q1
1 quarter
CRM icon
154
Salesforce
CRM
$198B
$515K 0.04%
2,002
-220
-10% -$58.9K
2023 Q1
5 quarters
BUD icon
155
AB InBev
BUD
$163B
$511K 0.04%
8,793
+1,754
+25% +$107K
2023 Q4
2 quarters
PANW icon
156
Palo Alto Networks
PANW
$280B
$509K 0.04%
3,002
+78
+3% +$11.7K
2023 Q1
5 quarters
SCHD icon
157
Schwab US Dividend Equity ETF
SCHD
$115B
$507K 0.04%
+19,554
New +$509K
2024 Q2
0 quarters
INTC icon
158
Intel
INTC
$475B
$501K 0.04%
16,189
-6,594
-29% -$216K
2020 Q1
17 quarters
CSCO icon
159
Cisco
CSCO
$423B
$500K 0.04%
10,527
-3,817
-27% -$181K
2022 Q3
7 quarters
PFE icon
160
Pfizer
PFE
$169B
$499K 0.04%
17,845
+2,551
+17% +$70.2K
2021 Q4
10 quarters
DSI icon
161
iShares MSCI KLD 400 Social ETF
DSI
$5.46B
$498K 0.04%
4,798
– –
2013 Q2
44 quarters
TTD icon
162
Trade Desk
TTD
$5.78B
$497K 0.04%
+5,085
New +$459K
2024 Q2
0 quarters
MFG icon
163
Mizuho Financial
MFG
$123B
$495K 0.04%
117,109
+30,330
+35% +$120K
2023 Q4
2 quarters
ADI icon
164
Analog Devices
ADI
$192B
$488K 0.04%
2,139
+271
+15% +$57.8K
2022 Q4
6 quarters
UBS icon
165
UBS Group
UBS
$146B
$486K 0.04%
16,455
+2,200
+15% +$65.4K
2024 Q1
1 quarter
SMFG icon
166
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$155B
$485K 0.04%
36,146
+7,264
+25% +$88K
2023 Q4
2 quarters
SPGI icon
167
S&P Global
SPGI
$127B
$483K 0.04%
1,084
+24
+2% +$10.3K
2022 Q4
6 quarters
QCOM icon
168
Qualcomm
QCOM
$184B
$482K 0.04%
2,421
+333
+16% +$62.9K
2022 Q4
6 quarters
SNY icon
169
Sanofi
SNY
$97.3B
$478K 0.04%
9,852
+4,685
+91% +$226K
2024 Q1
1 quarter
LIN icon
170
Linde
LIN
$230B
$476K 0.04%
1,084
+77
+8% +$33.9K
2022 Q4
6 quarters
HON icon
171
Honeywell
HON
$67B
$474K 0.04%
2,353
+142
+6% +$27K
2022 Q3
7 quarters
NUE icon
172
Nucor
NUE
$58.1B
$469K 0.04%
+2,966
New +$515K
2024 Q2
0 quarters
EOG icon
173
EOG Resources
EOG
$82.9B
$468K 0.04%
3,722
+45
+1% +$5.77K
2021 Q1
13 quarters
TMUS icon
174
T-Mobile US
TMUS
$171B
$468K 0.04%
2,657
+40
+2% +$6.71K
2021 Q4
10 quarters
ELV icon
175
Elevance Health
ELV
$92.9B
$466K 0.04%
860
+391
+83% +$207K
2024 Q1
1 quarter

Similar funds

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.